摘要
目的:观察盆底脱垂修补术后患者口服盐酸坦洛新片同时联合排尿监测、个体化选择拔尿管时间在预防术后尿潴留发生中的作用。方法:在2009年10月1日至2011年09月30入住我院的患者中选择126例全盆底修补术或前盆底修补术患者,随机分成两组,观察组69例,对照组57例,观察组予以盐酸坦洛新片口服并行个体化拔尿管;对照组予以安慰剂口服并采用传统的术后留置尿管方法。结果:观察组的术后尿潴留发生率为5.7%,对照组的尿潴留发生率为19.2%,观察组尿潴留发生率明显降低(P<0.05),其残余尿量、平均留置尿管时间亦均明显降低(P<0.05),且未观察到明显的药物不良反应。结论:盆底脱垂修补术后口服盐酸坦洛新片并进行排尿训练及个性化拔管对预防术后患者的尿潴留有明显效果,无明显不良反应,故该方法值得临床推广。
Objective: The aims of this study were to evaluate the clinical effect of tamsulosin hydrochloride combined monitoring urination and individual pull catheter in preventing postoperative urinary retention (PUR) of pelvic floor reconstruction surgery. Methods: Data were obtained from 126 consecutive patients undergoing transvaginal reconstructive surgery from 1 October 2009 to 30 September 2011, randomly divided into two groups: Observed group, 69 cases; Control group, 57 cases. Apply tamsulosin hydrochloride retard tablets to the Observed group, choose the time of pulling the urinary catheter according to the voiding volume, observe the effect; at the same time placebo was used to the Control group, traditionary urinary catheterization was also used. Results: The incidence of postoperative urinary retention of Observation group (5.7%), were significantly lower than Control group (19.2%). Conclusion: Oral tamsulosin hydrochloride combined with bladder training and personalized extubation can prevent postoperative urinary retention of patients undergoing pelvic reconstruction surgery. No obvious adverse reactions were found. This method was worthy of promotion.
出处
《现代生物医学进展》
CAS
2012年第30期5899-5901,共3页
Progress in Modern Biomedicine
关键词
盆底脱垂修补术
术后尿潴留
盐酸坦洛新片
个体化拔尿管
Pelvic floor reconstruction
Postoperative urinary retention
Tamsulosin
Individual pull catheter